1687. Antimicrobial Activity of Ceftibuten-Avibactam against a Global Collection of Enterobacterales from Patients with Complicated Urinary Tract Infections (2021)

BACKGROUND: Limited therapeutic options are currently available for oral treatment of complicated urinary tract infections (cUTIs) caused by resistant Enterobacterales (ENT). Ceftibuten (CTB) is an oral cephalosporin active against ENT approved by the US FDA in 1995. Avibactam (AVI) is a potent inhi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sader, Helio S, Carvalhaes, Cecilia G, Huband, Michael D, Mendes, Rodrigo E, Castanheira, Mariana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752981/
http://dx.doi.org/10.1093/ofid/ofac492.1317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752981/
http://dx.doi.org/10.1093/ofid/ofac492.1317

Ejemplares similares